Pharming Group N.V. (PHAR)

Pharming Group Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	92.09	54.94	61.74	207.34	191.92	205.16
Short-Term Investments	33.92	112.95	151.68	-	-	-
Cash & Short-Term Investments	126.01	167.89	213.42	207.34	191.92	205.16
Cash Growth	-21.40%	-21.33%	2.93%	8.03%	-6.45%	175.94%
Accounts Receivable	53.33	41.53	35.41	20.96	18.08	23.51
Other Receivables	-	8.64	7.21	4.37	9.52	8.37
Receivables	53.33	50.17	42.62	25.33	27.59	31.88
Inventory	63.72	55.72	56.76	42.33	27.31	21.16
Prepaid Expenses	-	4.65	3.54	2.29	2.39	4.02
Restricted Cash	2.73	-	-	0.21	0.23	1
Total Current Assets	245.78	278.44	316.34	277.5	249.44	263.21
Property, Plant & Equipment	24.57	24.13	33.47	39.15	33.17	21.65
Long-Term Investments	6.7	4.23	10.4	9.73	8.65	7.12
Other Intangible Assets	135.9	61.04	71.27	74.87	83.57	88.63
Long-Term Deferred Tax Assets	31.2	30.54	29.76	22.97	21.22	31.88
Long-Term Deferred Charges	-	-	-	0.25	0.27	5.46
Other Long-Term Assets	2.12	1.6	1.62	1.33	1.01	0.51
Total Assets	446.26	399.99	462.85	425.8	397.32	418.45
Accounts Payable	78.38	10.1	16.02	8.75	7.6	13.47
Accrued Expenses	-	53.22	50.27	43.61	33.34	33.4
Current Portion of Long-Term Debt	5.11	4.25	1.82	1.77	1.88	2.04
Current Portion of Leases	4.46	2.95	3.62	3.47	2.42	1.96
Current Income Taxes Payable	-	3.28	6.23	2.1	1.51	0.62
Other Current Liabilities	-	-	-	-	0.03	25.36
Total Current Liabilities	87.94	73.8	77.97	59.7	46.77	76.85
Long-Term Debt	91.27	78.15	136.6	131.62	139.01	149.73
Long-Term Leases	27.5	26.97	29.51	29.84	18.46	8.23
Other Long-Term Liabilities	-	-	-	-	0.17	0.21
Total Liabilities	206.71	178.92	244.07	221.16	204.4	235.02
Common Stock	7.82	7.77	7.67	7.51	7.43	7.31
Additional Paid-In Capital	491.85	488.99	478.43	462.3	455.25	447.13
Retained Earnings	-260.12	-287.92	-265.5	-265.17	-269.77	-271.01
Comprehensive Income & Other	-	12.23	-1.82	-	-	-
Shareholders' Equity	239.55	221.06	218.78	204.64	192.92	183.44
Total Liabilities & Equity	446.26	399.99	462.85	425.8	397.32	418.45
Total Debt	128.33	112.31	171.55	166.69	161.76	161.96
Net Cash (Debt)	-2.32	55.58	41.88	40.65	30.16	43.2
Net Cash Growth	-	32.72%	3.03%	34.76%	-30.18%	167.52%
Net Cash Per Share	-0.00	0.08	0.06	0.06	0.04	0.06
Filing Date Shares Outstanding	685.15	683.93	673.44	656.35	648.75	641.29
Total Common Shares Outstanding	685.15	680.31	671.07	656.35	648.75	638.82
Working Capital	157.83	204.64	238.37	217.8	202.67	186.36
Book Value Per Share	0.35	0.32	0.33	0.31	0.30	0.29
Tangible Book Value	103.65	160.02	147.51	129.77	109.35	94.81
Tangible Book Value Per Share	0.15	0.24	0.22	0.20	0.17	0.15
Land	-	-	-	-	0.03	0.03
Machinery	-	9.3	9.66	8.28	14.84	6.59
Construction In Progress	-	0.15	0.18	0.01	0.62	2.87
Leasehold Improvements	-	5.43	5.55	5.28	5.71	2.48

Updated Jul 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q